• bitcoinBitcoin(BTC)$80,738.000.91%
  • Midas Fasanara Global EuroMidas Fasanara Global Euro(MGLOEURO)$111,813.00-0.36%
  • ethereumEthereum(ETH)$2,345.781.13%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$743.580.32%
  • rippleXRP(XRP)$1.332.19%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$101.130.34%
  • tronTRON(TRX)$0.3310690.57%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.03-0.66%
  • zcashZcash(ZEC)$1,309.716.17%
  • HyperliquidHyperliquid(HYPE)$81.373.96%
  • dogecoinDogecoin(DOGE)$0.0787341.55%
  • moneroMonero(XMR)$605.371.18%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$77.560.93%
  • chainlinkChainlink(LINK)$11.541.51%
  • leo-tokenLEO Token(LEO)$9.050.13%
  • cardanoCardano(ADA)$0.205449-0.26%
  • nearNEAR Protocol(NEAR)$4.673.88%
  • stellarStellar(XLM)$0.1698050.66%
  • bitcoin-cashBitcoin Cash(BCH)$293.224.82%
  • RainRain(RAIN)$0.007177-5.72%
  • Ethena USDeEthena USDe(USDE)$1.000.03%
  • daiDai(DAI)$1.00-0.02%
  • litecoinLitecoin(LTC)$57.040.76%
  • uniswapUniswap(UNI)$7.07-1.14%
  • avalanche-2Avalanche(AVAX)$8.93-0.22%
  • CantonCanton(CC)$0.098668-0.60%
  • USD1USD1(USD1)$1.000.03%
  • suiSui(SUI)$0.931.62%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.231.44%
  • hedera-hashgraphHedera(HBAR)$0.075851-1.72%
  • tether-goldTether Gold(XAUT)$4,051.661.09%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • paypal-usdPayPal USD(PYUSD)$1.000.02%
  • BittensorBittensor(TAO)$255.251.74%
  • quant-networkQuant(QNT)$199.12-2.06%
  • shiba-inuShiba Inu(SHIB)$0.0000050.48%
  • EthenaEthena(ENA)$0.2078530.22%
  • crypto-com-chainCronos(CRO)$0.0537851.13%
  • BitwayBitway(BTW)$1.7448.23%
  • Ripple USDRipple USD(RLUSD)$1.00-0.03%
  • MemeCoreMemeCore(M)$1.0711.68%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.10%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • okbOKB(OKB)$109.270.04%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$133.60-1.42%
  • OndoOndo(ONDO)$0.4199591.29%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Smith & Wesson Brands, Inc. (SWBI) Q2 2025 Earnings Call Transcript

December 6, 2024
in Market & News
Reading Time: 2 mins read
A A
Smith & Wesson Brands, Inc. (SWBI) Q2 2025 Earnings Call Transcript
ShareShareShareShareShare

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) Q2 2025 Results Conference Call December 5, 2024 5:00 PM ET

Company Participants

YOU MAY ALSO LIKE

Pope Leo to undergo surgery to remove nodule on his lung

DMC Global Inc. (BOOM) Q3 2026 Earnings Call Transcript

Kevin Maxwell – General Counsel
Mark Smith – President and Chief Executive Officer
Deana McPherson – Chief Financial Officer

Conference Call Participants

Matthew Raab – Craig-Hallum
Rommel Dionisio – Aegis Capital
Mark Smith – Lake Street Capital Markets

Operator

Good day, everyone, and welcome to Smith & Wesson Brands’ Second Quarter Fiscal 2025 Financial Results Conference Call. This call is being recorded.

At this time, I would like to turn the call over to Kevin Maxwell, Smith & Wesson’s General Counsel, who will give some information about today’s call.

Kevin Maxwell

Thank you, and good afternoon. Our comments today may contain forward-looking statements. Our use of the words anticipate, project, estimate, expect, intend, believe and other similar expressions are intended to identify forward-looking statements. Forward-looking statements may also include statements on topics such as our product development, objectives, strategies, market share, demand, consumer preferences, inventory conditions for our products, growth opportunities and trends and industry conditions in general.

Forward-looking statements represent our current judgment about the future and are subject to risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by our statements today. These risks and uncertainties are described in our SEC filings, which are available on our website, along with a replay of today’s call. We have no obligation to update forward-looking statements.

We reference certain non-GAAP financial results. Our non-GAAP financial results exclude relocation expense and other costs. Reconciliations of GAAP financial measures to non-GAAP financial measures can be found in our SEC filings and in today’s earnings press release, each of which is available on our website. Also, when we reference EPS, we are always referencing fully diluted EPS, and any reference to EBITDA is to

Credit: Source link

ShareTweetSendSharePin

Related Posts

Pope Leo to undergo surgery to remove nodule on his lung
Market & News

Pope Leo to undergo surgery to remove nodule on his lung

October 27, 2026
DMC Global Inc. (BOOM) Q3 2026 Earnings Call Transcript
Market & News

DMC Global Inc. (BOOM) Q3 2026 Earnings Call Transcript

October 27, 2026
Israel election: Israeli exit polls suggest no clear winner with Eisenkot's bloc just ahead of Netanyahu – BBC
Market & News

Israel election: Israeli exit polls suggest no clear winner with Eisenkot's bloc just ahead of Netanyahu – BBC

October 27, 2026
Extended Interview: Why Michelle Buteau’s next special is a “love letter to tired Americans”
Market & News

Extended Interview: Why Michelle Buteau’s next special is a “love letter to tired Americans”

October 27, 2026
Next Post
Putin says Russia launched new weapon at Ukraine

Putin says Russia launched new weapon at Ukraine

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
ICE officers hit man running from them with SUV

ICE officers hit man running from them with SUV

October 27, 2026
Fortnite Is Coming Back To Apple’s Australian App Store Following Court Ruling

Fortnite Is Coming Back To Apple’s Australian App Store Following Court Ruling

October 22, 2026
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

October 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!